Seroprevalence of 2009 H1N1 Virus Infection and Self-Reported Infection Control Practices Among Healthcare Professionals Following the First Outbreak in Bangkok, Thailand

Influenza and other Respiratory Viruses

Volumn 7, Issue 3, 2013, Pages 359-363

  Chokephaibulkit, Kulkanya ^a   Assanasen, Susan ^a   Apisarnthanarak, Anucha ^b   Rongrungruang, Yong ^a   Kachintorn, Kanchana ^a   Tuntiwattanapibul, Yuwadee ^a   Judaeng, Tepnimitr ^a   Puthavathana, Pilaipan ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

2009 H1N1 pandemic; Healthcare workers; Hemagglutination assay; Seroprevalence; Thailand

Indexed keywords

ADULT; ARTICLE; EXPOSURE; FEMALE; GLOVE; HAND WASHING; HEALTH CARE PERSONNEL; HUMAN; INFECTION CONTROL; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; MASK; PRIORITY JOURNAL; RISK FACTOR; SEROPREVALENCE; THAILAND;

ADULT; ANTIBODIES, VIRAL; ATTITUDE OF HEALTH PERSONNEL; DISEASE OUTBREAKS; FEMALE; GUIDELINE ADHERENCE; HEALTH PERSONNEL; HUMANS; INFECTION CONTROL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; QUESTIONNAIRES; SELF REPORT; SEROEPIDEMIOLOGIC STUDIES; THAILAND; YOUNG ADULT;

EID: 84876458443     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12016     Document Type: Article

References (13)

1. WHO. Pandemic H1N1 2009- Thailand 31st March 2010. Available at http://www.searo.who.int/EN/Section10/Section2562_15043.htm (Accessed 22 February 2011).
2. Garcia-Garcia L, Valdespino-Gomez JL, Lazcano-Ponce E et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ 2009; 339:b3928.
3. Louisirirotchanakul S, Lerdsamran H, Wiriyarat W et al. Erythrocyte binding preference of avian influenza H5N1 viruses. J Clin Microbiol 2007; 45:2284-2286.
4. Kitphati R, Pooruk P, Lerdsamran H et al. Kinetics and longevity of antibody response to influenza A H5N1 virus infection in humans. Clin Vaccine Immunol 2009; 16:978-981.
5. Kiertiburanakul S, Apivanich S, Muntajit T et al. H1N1 2009 influenza among healthcare workers in a tertiary care hospital in Thailand. J Hosp Infect 2010; 74:300-302.
6. Lerdsamran H, Pittayawonganon C, Pooruk P et al. Serological Response to the 2009 Pandemic Influenza A (H1N1) Virus for Disease Diagnosis and Estimating the Infection Rate in Thai Population. PLoS ONE 2011; 6:e16164.
7. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010; 375:1100-1108.
8. Dawood FS, Jain S, Finelli L et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605-2615.
9. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009;58:521-524.
10. Apisarnthanarak A, Mundy LM. Factors associated with health care-associated 2009 influenza a (H1N1) virus infection among Thai health care workers. Clin Infect Dis 2010; 51:368-369.
11. Novel influenza A (H1N1) virus infections among health-care personnel - United States, April-May 2009. MMWR Morb Mortal Wkly Rep 2009;58:641-645.
12. Simmerman JM, Suntarattiwong P, Levy J et al. Influenza virus contamination of common household surfaces during the 2009 influenza A (H1N1) pandemic in Bangkok, Thailand: implications for contact transmission. Clin Infect Dis 2010; 51:1053-1061.
13. Chen MI, Lee VJ, Barr I et al. Risk factors for pandemic (H1N1) 2009 virus seroconversion among hospital staff, Singapore. Emerg Infect Dis 2010; 16:1554-1561.